Article Details
Retrieved on: 2023-11-18 19:56:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Wedbush reissued an outperform rating and issued a $12.00 price target on shares of Sutro Biopharma in a research report on Tuesday. Truist Financial ...
Article found on: www.defenseworld.net
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here